Modulation of in vitro cytokine release from human leukemic mast cells (HMC-1) by glucocorticoids

Skin Pharmacol. 1996;9(2):93-8. doi: 10.1159/000211403.

Abstract

Mast cells are well known effector cells not only in allergic but also in diverse acute and chronic inflammatory diseases. We have shown previously that these cells produce a broad spectrum of cytokines which might contribute to mast cell-dependent pathology. In the present study, we have investigated the influence of four potent glucocorticoids, methylprednisolone-aceponate, methylprednisolone-17-propionate, prednicarbate, and betametasone valerate (10(-5) M-10(-9) M), on the IL-1 beta, IL-3, IL-8, and tumor necrosis factor alpha secretion of the HMC-1 mast cell line as measured by ELISA. All four glucocorticoids caused a comparable dose- and time-dependent inhibition of cytokine release from HMC-1 cells stimulated for 24 h with phorbol 12-myristate 13-acetate 25 ng/ml and calcium ionophore 2 x 10(-7) M. These results shed further light on the mechanisms involved in antiinflammatory effects of glucocorticoids in allergic inflammation.

MeSH terms

  • Administration, Topical
  • Anti-Inflammatory Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • Glucocorticoids
  • Humans
  • Interleukins / metabolism*
  • Mast Cells / drug effects*
  • Mast Cells / metabolism
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / metabolism
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Anti-Inflammatory Agents
  • Glucocorticoids
  • Interleukins
  • Tumor Necrosis Factor-alpha